From the *Rochester General Hospital Research Institute; and †Legacy Pediatrics, Rochester, NY.
Pediatr Infect Dis J. 2013 Nov;32(11):1159-62. doi: 10.1097/INF.0b013e31829e3779.
We sought to determine whether recurrent acute otitis media (rAOM) occurring within 30 days of amoxicillin/clavulanate treatment was caused by bacterial relapse or new pathogens.
Pneumococcal conjugate vaccinated children, age 6-36 months, enrolled in a prospective, longitudinal study experiencing rAOM<1 month after completing amoxicillin/clavulanate therapy were studied. AOM episodes occurred between June 2006 and November 2012. Multilocus sequence typing was used to genotype isolates.
Sixty-six children were in the study cohort; 63 otopathogens were recovered from middle ear fluid after tympanocentesis. Nontypeable Haemophilus influenzae (NTHi) accounted for 47% of initial AOMs versus 15% by Streptococcus pneumoniae (Spn), P<0.0001. NTHi accounted for 42% of rAOM versus 24% by Spn (P value=0.04). NTHi was the main otopathogen that caused true bacteriologic relapses (77%). β-lactamase-producing NTHi and penicillin nonsusceptible Spn were not more common in rAOM than initial AOM infections. Among 21 paired (initial and rAOM events) NTHi isolates genotyped, 13 (61.9%) were the same organism; 1 of 9 (11.1%) of paired Spn isolates was the same (P value=0.017). rAOM occurring within a week of stopping amoxicillin/clavulanate was a different pathogen in 21% of cases, 8-14 days later in 33%, 15-21 days in 41% and 22-30 days in 57% (P=0.04).
In amoxicillin/clavulanate-treated children, NTHi was the main otopathogen that caused true bacteriologic relapses. New pathogens causing rAOM versus persistence of the initial pathogen significantly increased week to week. Neither relapses nor new infections were caused more frequently by β-lactamase producing NTHi or penicillin nonsusceptible Spn.
我们旨在确定在阿莫西林/克拉维酸治疗后 30 天内发生的复发性急性中耳炎(rAOM)是由细菌复发还是新病原体引起的。
我们对接受了肺炎球菌结合疫苗接种的 6-36 月龄儿童进行了前瞻性纵向研究,这些儿童在完成阿莫西林/克拉维酸治疗后 1 个月内经历了 rAOM<1 个月。中耳炎发作发生在 2006 年 6 月至 2012 年 11 月之间。使用多位点序列分型来对分离株进行基因分型。
在研究队列中有 66 名儿童;63 个耳病原体从鼓室穿刺后的中耳液中回收。未分型流感嗜血杆菌(NTHi)占初始 AOM 的 47%,而肺炎链球菌(Spn)占 15%,<0.0001。NTHi 占 rAOM 的 42%,而 Spn 占 24%(P 值=0.04)。NTHi 是引起真正细菌复发的主要耳病原体(77%)。rAOM 中产生β-内酰胺酶的 NTHi 和耐青霉素的 Spn 并不比初始 AOM 感染更常见。在 21 对(初始和 rAOM 事件)NTHi 分离株进行基因分型中,13 对(61.9%)为同一病原体;9 对 Spn 分离株中有 1 对(11.1%)相同(P 值=0.017)。在停止阿莫西林/克拉维酸治疗后一周内发生的 rAOM 在 21%的情况下是另一种病原体,8-14 天后为 33%,15-21 天后为 41%,22-30 天后为 57%(P=0.04)。
在接受阿莫西林/克拉维酸治疗的儿童中,NTHi 是引起真正细菌复发的主要耳病原体。rAOM 的新病原体与初始病原体的持续存在相比,每周显著增加。β-内酰胺酶产生的 NTHi 或耐青霉素的 Spn 均未更频繁地引起复发或新感染。